Skip to main content

US ClosedU.S. Closed

BCAX: Bicara Therapeutics Inc. Common Stock Stock Analysis | finqOS

Healthcare · Biotechnology

Bicara Therapeutics Inc. , a biopharmaceutical firm in the clinical development phase, is headquartered in Boston, Massachusetts.

52W Range

63rdpctl

Volume

0.80×avg

Market Cap

1.54BUSD

P/E Ratio

-7.6TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Bicara Therapeutics Inc. Common Stock

BCAXNASDAQ Global Market·USD·Closed

Bicara Therapeutics Inc. Common Stock

BCAXNASDAQ·USD·Closed

$23.43

−5.64%

$23.43

−$1.40 (5.64%)

52W Range

63rdpctl

Volume

0.80×avg

Mkt Cap

1.54BUSD

P/E

-7.6TTM

Div Yield

–ann